Cite
HARVARD Citation
Maleki, A. et al. (2022). Response to the Second TNF-α Inhibitor (Adalimumab or Infliximab) after Failing the First One in Refractory Idiopathic Inflammatory Retinal Vascular Leakage. Ocular immunology and inflammation. pp. 1099-1108. [Online].